Condividi contenuti The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Aggiornato: 30 min 38 sec fa

Lombard Medical's Aorfix(TM) Endovascular Stent Graft Adopted by Surgeons at Veteran Affairs Medical Centers

Gio, 10/09/2014 - 13:17
Highlights Value of Uniquely Broad Label for Treating Patients With Abdominal Aortic Aneurysms, Including Those With Complex Anatomies IRVINE, Calif. and LONDON, Oct. 9, 2014 -- (Healthcare Sales & Marketing Network) -- Lombard Medical, Inc. (EVAR), a m...
Devices, Interventional
Lombard Medical, endovascular aneurysm repair, Aorfix , AAA

Cortendo Appoints Robert Lutz as Chief Business Officer

Gio, 10/09/2014 - 13:06
GÖTEBORG, Sweden & RADNOR, Penn.--(Healthcare Sales & Marketing Network)--Cortendo AB [ticker: CORT on NOTC-A], a global biopharmaceutical company focused on orphan endocrine disorders, announced the appointment of Robert Lutz as Chief Business Office...
Biopharmaceuticals, Personnel
Cortendo

EndoGastric Solutions Announces Publication of Study Demonstrating Benefits of TIF Procedure in Controlling GERD Symptoms

Mer, 10/08/2014 - 13:19
Prospective, Randomized Study Showed Durability of Clinical Outcomes in the TIF Group and Improved Control of GERD symptoms in the Crossover Group SAN MATEO, Calif.--(Healthcare Sales & Marketing Network)--EndoGastric Solutions® (EGS), a leader in e...
Devices, Gastroenterology
EndoGastric Solutions, Transoral Incisionless Fundoplication, GERD

Masimo Announces CE Mark of the 11th Rainbow(R) Parameter - ORI(TM), Oxygen Reserve Index(TM)

Mer, 10/08/2014 - 13:11
First Noninvasive & Continuous Parameter to Provide Insight Into Oxygen Reserve in Patients Receiving Supplemental Oxygen NEUCHATEL, SWITZERLAND--(Healthcare Sales & Marketing Network) - Masimo (NASDAQ: MASI) today announced CE Mark and limited market r...
Devices, Monitoring, Regulatory
Masimo, Oxygen Reserve Index

Kubtec(R) Announces FDA Approval of World’s First Breast Specimen Tomosynthesis System During Breast Cancer Awareness Month

Mer, 10/08/2014 - 13:03
MOZART® with TomoSpec®: 3D Specimen Imaging Technology From Kubtec MILFORD, Conn.--(Healthcare Sales & Marketing Network)--Kubtec, the foremost developer of digital specimen radiography systems, marks the start of Breast Cancer Awareness Month w...
Devices, FDA
Kubtec, MOZART, TomoSpec , tomosynthesis

CardiacAssist Announces the First Human Use of Its PROTEK DUO(TM) Veno-Venous ECLS Kit

Mar, 10/07/2014 - 13:51
Texas man is the world’s first to receive the PROTEK Duo for treatment following surgery PITTSBURGH--(Healthcare Sales & Marketing Network)--CardiacAssist, Inc. today announced that the first PROTEK Duo veno-venous extracorporeal life support (VV ECLS) ...
Devices, Interventional Cardiology
CardiacAssist, PROTEK DUO, extracorporeal life support, TandemHeart

RepliCel Life Sciences Adds Industry Specialist to Management Team

Mar, 10/07/2014 - 13:46
Newly Appointed Vice-President of Business & Corporate Development to Drive External Initiatives VANCOUVER, BRITISH COLUMBIA--(Healthcare Sales & Marketing Network) - RepliCel Life Sciences Inc. (REPCF)(TSX VENTURE:RP), a clinical stage regenerative med...
Regenerative Medicine, Personnel
RepliCel Life Sciences

Pinnacle Biologics, Inc., a subsidiary of Concordia Healthcare Corp., announces European site initiation of Phase 3 bile duct cancer trial using photodynamic therapy with PHOTOFRIN(R)

Mar, 10/07/2014 - 13:38
University of Mannheim Medical Center is first site opened TORONTO and CHICAGO, Oct. 7, 2014 -- (Healthcare Sales & Marketing Network) - Pinnacle Biologics, Inc. ("Pinnacle"), a subsidiary of Concordia Healthcare Corp., ("Concordia"...
Biopharmaceuticals, Oncology
Concordia Healthcare, Pinnacle Biologics, PHOTOFRIN, Photodynamic therapy

Miramar Labs Expands Management Team

Mar, 10/07/2014 - 13:22
Miramar Labs Appoints Rob Ellis as VP of Marketing SANTA CLARA, Calif., Oct. 7, 2014 /PRNewswire-iReach/ -- Miramar Labs® Inc., a leading medical device manufacturer and maker of the miraDry® System, today announced the expansion of its manageme...
Devices, Personnel
Miramar Labs, miraDry

Claret Medical Announces First Patient Treated in U.S. Pivotal Trial Evaluating Cerebral Protection During Transcatheter Aortic Valve Replacement (TAVR)

Lun, 10/06/2014 - 15:32
Randomized Controlled SENTINEL Trial is the First in the U.S. to Study Capture and Removal of Debris Released During TAVR That May Otherwise Be the Source of Stroke SANTA ROSA, Calif.--(Healthcare Sales & Marketing Network)--Claret Medical, Inc., a deve...
Devices, Interventional Cardiology
Claret Medical, Cerebral Protection, TAVR, transcatheter, aortic valve

bioTheranostics Appoints Nicolas Barthelemy as President and CEO

Lun, 10/06/2014 - 15:28
Industry Veteran to Lead Organization as It Expands Commercialization of Its Molecular Diagnostic Tests for Breast and Metastatic Cancers SAN DIEGO--(Healthcare Sales & Marketing Network)--bioTheranostics, Inc., a leader in molecular diagnostics for can...
Diagnostics, Oncology, Personnel
bioTheranostics, molecular diagnostic, Breast Cancer Index

Zavation Launches ZVPlasty(TM) for the treatment of Spinal Fractures

Lun, 10/06/2014 - 15:25
FLOWOOD, Miss., Oct. 6, 2014 -- (Healthcare Sales & Marketing Network) -- Zavation, LLC., today announced the launch of the ZVPlasty™ Vertebral Augmentation System. The Zavation ZVPlasty™ is designed for use in vertebroplasty or kyphoplasty procedures ...
Devices, Orthopaedic, Neurosurgery, Product Launch
Zavation, ZVPlasty, vertebroplasty, kyphoplasty

Mylan Launches Generic Combivir

Lun, 10/06/2014 - 15:23
Product strengthens growing antiretroviral franchise in the U.S. PITTSBURGH, Oct. 3, 2014 -- (Healthcare Sales & Marketing Network) -- Mylan Inc. (MYL) today announced the U.S. launch of its Lamivudine and Zidovudine Tablets USP, 150 mg/300 mg, which i...
Biopharmaceuticals, Generics, HIV/AIDS, Product Launch
Mylan, Combivir, Lamivudine, Zidovudine

Ophthotech Corporation Names Todd N. Smith as Chief Commercial Officer

Ven, 10/03/2014 - 13:05
Ophthotech Broadens and Strengthens its Senior Leadership Team Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) NEW YORK--(Healthcare Sales & Marketing Network)--Ophthotech Corporation (OPHT) announced that Todd N. Smith has joined the ...
Biopharmaceuticals, Ophthalmology
Ophthotech

Allied-Bristol Life Sciences Appoints Former Bristol-Myers Vice President Satish Jindal to Lead the Discovery of Drug Candidates From Leading Academic Institutions

Ven, 10/03/2014 - 12:57
BOSTON--(Healthcare Sales & Marketing Network)--Allied-Bristol Life Sciences LLC, a jointly owned enterprise between Allied Minds (ALM.L) and Bristol-Myers Squibb Co., today announced that Satish Jindal, Ph.D., formerly Vice President of R&D within Bristol...
Biopharmaceuticals, Personnel
Allied-Bristol Life Sciences, Allied Minds, Bristol-Myers Squibb

Salix Pharmaceuticals and Cosmo Technologies Announce Termination of Merger Agreement

Ven, 10/03/2014 - 12:51
RALEIGH, N.C. & LAINATE, Italy--(Healthcare Sales & Marketing Network)--Salix Pharmaceuticals, Ltd. (“Salix”) (SLXP) and Cosmo Pharmaceuticals S.p.A. (“Cosmo”) (COPN.SW) today announced that they have agreed to terminate their previously-announced merger a...
Biopharmaceuticals, Mergers & Acquisitions
Salix Pharmaceuticals, Cosmo Pharmaceuticals

Esaote Receives FDA Clearance for Its Portable MyLab Gamma Ultrasound System

Gio, 10/02/2014 - 15:15
Highly portable ultrasound delivers affordable, feature-rich performance for shared service imaging INDIANAPOLIS--(Healthcare Sales & Marketing Network)--Esaote North America announced that its new MyLab Gamma ultrasound system has received 510(k) clear...
Devices, FDA
Esaote, MyLab Gamma, ultrasound, imaging

EarlySense Welcomes Mr. John Barr as a New Member to the Board of Directors

Gio, 10/02/2014 - 15:11
RAMAT GAN, Israel, October 2, 2014 -- (Healthcare Sales & Marketing Network) --EarlySense®, the market leader in contact-free monitoring solutions announced today that Mr. John Barr, medical device executive and industry expert has joined the company'...
Devices, Monitoring, Personnel
EarlySense

Lilly to Discontinue Development of Tabalumab Based on Efficacy Results in Phase 3 Lupus Studies

Gio, 10/02/2014 - 15:08
INDIANAPOLIS, Oct. 2, 2014 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (LLY) announced today it will discontinue development of tabalumab - being studied for the treatment of systemic lupus erythematosus (SLE, commonly known as lup...
Biopharmaceuticals
Eli Lilly, tabalumab­, systemic lupus erythematosus

Cardio3 Biosciences Announces New Business Development Strategy To Broaden Its Product Pipeline

Mer, 10/01/2014 - 10:05
Cardio3 BioSciences' business development strategy will be articulated around a technology pillar - cellular therapies - and a clinical application pillar - cardiovascular diseases - to further strengthen its long term growth This strategy aims to expan...
Regenerative Medicine
Cardio3 BioSciences, C-Cathez, C-Cure

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong